Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Brendan Smith is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 09/20/2024 | DNA | Buy Now | Ginkgo Bioworks Holdings | $7.73 | 29.37% | Brendan Smith36% | $3 → $10 | Maintains | Buy | Get Alert |
| 08/09/2024 | EXAI | Buy Now | Exscientia | — | — | Brendan Smith36% | — | Downgrade | Buy → Hold | Get Alert |
| 08/07/2024 | HALO | Buy Now | Halozyme Therapeutics | $64.55 | 0.7% | Brendan Smith36% | $59 → $65 | Maintains | Buy | Get Alert |
| 07/09/2024 | EXAI | Buy Now | Exscientia | — | — | Brendan Smith36% | — | Initiates | → Buy | Get Alert |
| 05/13/2024 | NVAX | Buy Now | Novavax | $7.89 | 26.7% | Brendan Smith36% | $5 → $10 | Maintains | Hold | Get Alert |
| 02/29/2024 | HALO | Buy Now | Halozyme Therapeutics | $64.55 | -16.34% | Brendan Smith36% | → $54 | Initiates | → Outperform | Get Alert |
| 07/21/2023 | ARWR | Buy Now | Arrowhead Pharma | $15.47 | — | Brendan Smith36% | — | Initiates | → Outperform | Get Alert |
| 12/05/2022 | DNLI | Buy Now | Denali Therapeutics | $14.82 | — | Brendan Smith36% | — | Initiates | → Outperform | Get Alert |
